Ideal or actual body weight to calculate CD34+ cell doses for allogeneic hematopietic stem cell transplantation?

J. Cilley, C. Rihn, J. Monreal, L. I. Gordon, S. Singhal, M. Tallman, S. Williams, J. Winter, J. Mehta*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

The number of CD34+ cells infused influences hematologic recovery after transplantation. Limited data suggest that cell dose should be based on ideal (IBW) rather than actual (ABW) body weight for autotransplantation, but none in allografts. We compared the correlation between recovery to 0.5 × 109/l neutrophils and the CD34 + cell dose based upon ABW and IBW in 78 allograft recipients. ABW was ≥25% over IBW in 47% of patients. The median CD34+ cell dose was 5.1 × 106/kg IBW and 4.4 × 106/kg ABW. The time to neutrophil recovery was 8-26 days (median 12). There was a stronger inverse correlation between CD34+ cell dose/IBW and neutrophil recovery (r2 = 0.160; P<0.0001) than between CD34+ cell dose/ABW and neutrophil recovery (r2 = 0.138; P=0.001). When neutrophil recovery in patients receiving <3 or < 5 × 106 CD34+ cells/kg was compared to those receiving ≥3 or ≥5 × 106 CD34+ cells/kg, respectively, separately by IBW and ABW, the magnitude and significance of the differences were greater for IBW-based comparisons. These data suggest the CD34+ cell dose based on IBW is a better predictor of neutrophil recovery after allografting. Further work in a larger, more homogeneous group of patients is required to confirm this observation.

Original languageEnglish (US)
Pages (from-to)161-164
Number of pages4
JournalBone Marrow Transplantation
Volume33
Issue number2
DOIs
StatePublished - Jan 2004

Keywords

  • Allogeneic hematopoietic stem cell transplantation
  • CD34+ cells
  • Engraftment
  • Myeloid recovery
  • Weight

ASJC Scopus subject areas

  • Transplantation
  • Hematology

Fingerprint

Dive into the research topics of 'Ideal or actual body weight to calculate CD34+ cell doses for allogeneic hematopietic stem cell transplantation?'. Together they form a unique fingerprint.

Cite this